Article
Pan-cancer analysis reveals potential of FAM110A as a prognostic and immunological biomarker in human cancer
27 Feb 2023
Abstract excerpt
Background: Despite great success, immunotherapy still faces many challenges in practical applications. It was previously found that family with sequence similarity 110 member A (FAM110A) participate in the regulation of the cell cycle and plays an oncogenic role in pancreatic cancer. However, the prognostic value of FAM110A in pan-cancer and its involvement in immune response remain unclear. Methods: The Human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
